SABIC’s Plants in Brazil and Argentina Earn Certification to Produce FDA-Compliant, Biocompatible Resins for Burgeoning S.A. Healthcare Market

Published Jan 12, 2012

PITTSFIELD, Mass. – Jan. 12, 2012 – SABIC’s Innovative Plastics business today announced that its manufacturing facilities in Campinas, Brazil and Tortuguitas, Argentina, are now certified to produce U.S. Food and Drug Administration (FDA)-compliant and biocompatible resins for the fast-growing South American healthcare market to help slash lead times, reduce inventory costs and increase flexibility in material purchasing. Medical markets in eight Latin and South American countries, including Brazil, Mexico, Argentina, and Chile, are expected to demonstrate a compound annual growth rate (CAGR) of 4.6 percent between 2008 and 2013, reaching U.S. $9.2 billion, according to Espicom Health Intelligence. To meet this increasing demand, SABIC is committed to providing local customers fast and easy access to high-performance materials – such as biocompatible Lexan* HP polycarbonate (PC) resins – and technical resources that they need to bring the next generation of medical applications to market.